We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
Updated: 12/31/1969
A Single-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of Prednisolone Sodium Phosphate Ophthalmic Solution, 1% Compared to Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated: 12/31/1969
Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
Updated: 12/31/1969
A Single-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of Prednisolone Sodium Phosphate Ophthalmic Solution, 1% Compared to Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Updated: 12/31/1969
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Updated: 12/31/1969
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 12/31/1969
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Updated: 12/31/1969
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Updated: 12/31/1969
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Updated: 12/31/1969
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
